Former Corrections Officer Speaks After Termination From State
Corrections officers said working inside the state's prisons is just too dangerous.
'At Upstate we had several exposures,' said Deven Hooper, a former C.O. (corrections officer) at Upstate Correctional Facility, in Malone, New York. 'There had been several safety situations that had come up before that. We were trying to get people's attention that there was something going on, that we needed help.
During the same period, The Department of Corrections and Community Supervision (DOCCS) Commissioner, Daniel Martuscello, sent out a memo advising that 70% staffing would become the new 100%.
'We had been running our facilities at 70 percent so well that it was going to become our new norm, our 100 percent,' said Hooper.
That is when thousands of corrections officers at 38 of New York's 42 prisons staged an unsanctioned strike.
For 22 days officers, along with family, friends, and supporters stood outside their respective prisons demanding one major change.
'The only thing that we really wanted out of this was safety inside the facilities, for the corrections officers, for the guys that work down back and for the incarcerated individuals.
The state responded by issuing notices.
During one of several online press conferences, Martuscello was joined by the commissioner for Homeland Security and Emergency Services, Jackie Bray.
'Yesterday, we began terminations of corrections officers. Today, we terminated health insurance for officers who have been AWOL,' said Bray.
Hooper is still trying to come to terms with losing his health insurance.
'I have 3 kids at home. I have a wife. I support all of them. To suddenly have my insurance cut off…,' said Hooper. 'We struggle, but we find ways to get around it. If she wants to cut off our insurance, so be it. We're better than that. We knew she was playing a game from the beginning.
During all of this, mediations and negotiations took place. The state put out several officers, but the officers rejected them, saying that the safety issues were not corrected.
'It didn't address the safety situations. As for the HALT Act, it was only a 90 day stop on HALT,' said Hooper. 'It's just a band-aid for the situation.'
The final offer from the state came out last Saturday. It was dependent on 85 percent of officers returning to work on Monday.
Even though only 77 percent returned, leaving at least 2,000 officers behind, it was enough for the state to honor the deal anyway.
'I understand everybody has their own situations. Everybody has their own reasons for going back,' said Hooper. 'But I, personally, couldn't cross the line, not for the deal that came down through the line, not for the lack of safety that came through.'
Those that did not return were sent termination letters from the state.
'Termination letters have been sent to over 2,000 people who have remained on strike,' said Martuscello, at Monday's online press conference.
Hooper, along with the remaining officers on strike at Upstate Correctional Facility, say despite being fired, they're proud to stand up for what they know is right.
'I'll stand here until the very last day,' said Hooper.
Just a few days after the strike ended, Gov. Kathy Hochul signed an executive order banning those officers from working any state-related positions, including police forces.
Considering the dire need for more corrections officers in the state, even before all this, it's still unclear if some sort of reconciliation is likely or even possible.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


American Press
23-07-2025
- American Press
Cassidy: Fentanyl bill 'one more tool for law enforcement'
U.S. Sen, Bill Cassidy, M.D. (R-LA), is chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee. (Special to the American Press) Legislation spearheaded by U.S. Sen. Cassidy was signed by President Donald Trump last week. The Halt All Lethal Trafficking (HALT) Fentanyl Act solidifies the classification of fentanyl-related substances as Schedule 1 of the Controlled Substances Act, which is the category for drugs, substances or chemicals with no currently accepted medical use and a high potential for abuse. Fentanyl is a synthetic opioid that is 50 times stronger than heroin and 100 times stronger than morphine, according to the Center for Disease Control and Prevention. Drug overdoses in the United States are predominantly fentanyl-related, contributing to nearly 70 percent of overdose deaths. Fentanyl will be listed at a Schedule 1 drug alongside substances like LSD and cannabis. HALT, which was passed by the U.S. Senate in March, is just 'one more tool for law enforcement to help prevent fentanyl,' Cassidy said during a press briefing on Tuesday. A ceremony for the executive signing of the act was help on Wednesday, July 16. 'During the ceremony, President Trump thanked me, said that this bill is one of the most important things that he will sign this year,' Cassidy said. 'I will agree. One life lost to drug overdoses is too many lives, and we may have as many as 50,000 to 60,000 to 70,000 lives lost annually from fentanyl overdose.' Cassidy thanked Trump in return for addressing the fentanyl epidemic. 'He has worked hard by securing the border, going out to cartels and asking the Chinese to not ship fentanyl precursors to decrease the epidemic. U.S. Customs and Border Protection (CBP) seized 21.9 thousand pounds of fentanyl in 2024. So far this year. As of July 15, CBP has seized 9.2 thousand pounds of fentanyl in 2025. Coca-Cola This week, Coca-Cola announced that the company will expand its product line to include Coca-Cola products made with U.S. Cane Sugar. In the second quarter of 2025 company's report that was released on Tuesday, Coca-Cola said the 'addition is designed to … offer more choices across occasions and preferences.' Cassidy called it a 'great move by President Trump to make America healthier again' that will economically benefit Louisiana through the increased need for sugar. 'Of course, a lot of that sugar is going to come from Louisiana,' he said. 'The cane sugar from Louisiana will be actually healthier than the other type of sugar that they're currently using … and it will obviously give an economic boost to our guys.'


Business Wire
21-07-2025
- Business Wire
PBI-Gordon Companies, Inc. Calls on Petspan to Cease and Desist False and Misleading Advertisement, Promotion and Sale of Compounded Rapamycin (Sirolimus) for HCM in Cats
SHAWNEE, Kan.--(BUSINESS WIRE)--PBI-Gordon Companies, Inc. the parent company of TriviumVet, which holds sole conditional new animal drug approval from the FDA for Felycin ® -CA1 (sirolimus delayed-release tablets) under its affiliated brand company Pegasus, through its outside counsel issued a cease-and-desist demand letter to Petspan for falsely promoting a compounded version of rapamycin (synonymous with sirolimus) for the treatment and management of clinical hypertrophic cardiomyopathy (HCM) in cats. Petspan's evaluation and prescribing practices do not comply with established veterinary practice principles and places the health and wellbeing of cats in jeopardy. Felycin-CA1 is the first and only drug to receive FDA conditional approval for management of ventricular hypertrophy with subclinical HCM in cats. It is also the only conditionally approved drug for which treatment claims are permitted based on studies that were conducted by or on behalf of the holder of the cNADA, TriviumVet. This conditional approval was announced in an FDA press release dated March 14, 2025. Pegasus Laboratories, Inc. ('Pegasus'), another wholly owned subsidiary of PBI-Gordon, launched Felycin-CA1 under the PRN Pharmacal brand at the American College of Veterinary Internal Medicine Forum held June 17-20, 2025, where veterinarians and other participants in attendance were made aware of the availability of Felycin-CA1 through standard distribution channels. PBI-Gordon asserts Petspan is engaging in a pervasive pattern of intentionally false and misleading communications aimed at both veterinarians and pet owners, including claiming product legitimacy from two clinical trials (RAPACAT and HALT-HCM trials) sponsored and conducted by TriviumVet, not Petspan. TriviumVet is currently conducting the HALT-HCM study which is necessary to produce the data required to advance Felycin-CA1 from a conditionally approved drug to a fully approved drug. Petspan's false and misleading public assertions imply that the safety and efficacy of TriviumVet's Felycin-CA1 are applicable to the Petspan compounded product. 'Petspan is illegally marketing an unapproved, unlicensed and potentially unsafe would-be copy of our product, and that has to be stopped,' said PBI-Gordon Companies, Inc. President & CEO Steve Clifford, 'We will take action to stop those who threaten patient safety and urgently call on regulators and law enforcement to do the same.' PBI-Gordon intends to pursue all necessary actions and legal remedies to ensure its product and intellectual property are protected against the false and misleading advertisement and sale of all unapproved versions of sirolimus for HCM, online or otherwise. Feline HCM is extremely common, affecting 1 in 7 of all pet cats. In animals 9 years of age and older, the prevalence rises to approximately 1 in 3 and is a leading cause of mortality in adult cats. The disease is characterized by abnormal thickening and impaired function of the ventricular wall of the heart. While some cats remain asymptomatic, around half go on to develop congestive heart failure or other severe complications. Subclinical HCM refers to cases that have ventricular wall thickening but have not yet developed clinical signs. 'Petspan's unlawful sale of its compounded drug – called Rapamycin – and its false and misleading promotion, poses a real danger to thousands of cats with this condition, and is a callous affront to their owners and veterinarians,' said Dr. Heather Davis DVM, PhD, DACVS-LA, Director of Clinical Affairs and Veterinary Services, Pegasus Laboratories, Inc. PBI-Gordon is also aware that Petspan advertises the diagnosis of HCM and prescription of its compounded 'rapamycin' through telemedicine visits with purported veterinarians. Current gold standard as established by veterinary boards, is to diagnose HCM in-person which involves a veterinarian physically performing a thorough evaluation to rule out other medical conditions that may present as HCM; clinical pathology sampling at a minimum is required in addition to physical examination to make such an assessment. Virtual telemedicine visits are insufficient to establish the relationship, diagnosis, and treatment protocol implementation for HCM in cats. A virtual treatment protocol that misdiagnoses HCM risks negative adverse events to the pet and harm to the future utility of Felycin-CA1 for HCM. More specifically, the letter demands that Petspan immediately cease and desist the following activities: Advertising compounded rapamycin (sirolimus) for the treatment of HCM in cats Relying on studies conducted by or on behalf of TriviumVet as the basis for the Petspan treatment protocol Posting misleading promotional and advertising materials on Petspan's website and social media, including references to studies conducted by or on behalf of TriviumVet Confusing the public by using a synonym for the drug (sirolimus) for which FDA approved the cNADA (i.e., 'rapamycin') About PBI-Gordon Companies PBI-Gordon Companies has been in business in the Kansas City metro area since 1947 and is 100 percent employee-owned. It is the parent company to four subsidiaries which develop, manufacture, and market leading products for Turf and Ornamental Industries (PBI-Gordon Corporation), Companion Animal Pharmaceuticals (Pegasus Laboratories & TriviumVet), and Companion Animal Nutritional Supplements and Grooming Supplies (PetAg). About Pegasus Laboratories Founded in 1986, Pegasus Laboratories is a pharmaceutical development and manufacturing organization focused on novel products to treat chronic conditions in cats, dogs, and horses. Pegasus provides full-service Contract Development and Manufacturing Organization (CDMO) focusing on the development and manufacturing with full turn-key technical services in a DEA-approved CGMP facility. Pegasus also provides a full portfolio of pharmaceuticals, nutritional therapeutics and supplements, parasite control and surgical and wound care under the PRN® and Sē·Qual™ brands. About TriviumVet TriviumVet is an Ireland-based research and development company. Working with some of the leading veterinarians and therapeutic specialists around the world to address the gaps in disease management by developing innovative new therapeutic solutions for some of the most serious and underserved conditions. Focused on finding effective treatments for unmet needs in cardiology, renal health, pain management, gastroenterology, wellness testing, and age-related diseases.
Yahoo
19-07-2025
- Yahoo
D.C. Dispatch: Iowa legislators cheer fentanyl reclassification, federal spending cuts
President Donald Trump signs the HALT Fentanyl Act, July 16, 2025, in the East Room of the White House. Iowa Sen. Chuck Grassley is second from the right. (Official White House Photo by Daniel Torok) This week in the nation's capital, President Donald Trump signed a fentanyl reclassification act led by Iowa Sen. Chuck Grassley, Iowa legislators cheered the passing of a federal rescission bill through Congress and House members helped send a $832 billion defense appropriations bill through the GOP-led chamber. The Grassley-led HALT Act permanently reclassifies fentanyl-related substances as a Schedule 1 drug. In February 2020, the U.S. Drug Enforcement Administration issued a temporary scheduling order reclassifying fentanyl-related substances to Schedule 1. Congress has since extended this order a total of 10 times. The act has received criticism from advocacy groups such as the Leadership Conference on Civil and Human Rights stating that classwide drug rescheduling may exacerbate incarceration rates and sentencing. The president's signing of the HALT Act Wednesday was attended by several Iowa officials including Grassley, Attorney General Brenna Bird and Rep. Randy Feenstra. 'The HALT Fentanyl Act is now the law of the land, marking a major victory in America's fight against fentanyl,' Grassley said in a press release. 'By permanently classifying fentanyl-related substances as Schedule I, the HALT Fentanyl Act will save American lives and prevent deadly fentanyl knockoffs from making their way into Iowa communities.' 'This bill is a huge win for Iowa and the entire country,' Bird said in a press release. 'As a mom and prosecutor, I am deeply aware of the devastating effects fentanyl has had on our communities. And as Attorney General, I hear about this issue from Iowans regularly. 'I applaud President Trump for signing into law the HALT Fentanyl Act and taking decisive action to keep fentanyl and other poisonous substances out of our country.' Feenstra stated. 'In conjunction with our work to secure the border, this legislation will help law enforcement confiscate dangerous drugs, combat the drug cartels, and save lives.' Rep. Ashley Hinson stated: 'This bill will help end the scourge of the opioid epidemic that has taken too many American lives — we will continue working together to get dangerous drugs off our streets & ensure dealers are punished for their crimes.' Rep. Zach Nunn also stated he 'proudly cosigned' the HALT act for its ability to 'crack down on traffickers,' keep 'deadly substances off our streets' and ensure consistent penalties for fentanyl distributors. Rep. Mariannette Miller-Meeks stated in a press release: 'As an original cosponsor in the House, I was proud to help lead the fight to get this bill across the finish line. With this law in place, we're going on offense. We're giving law enforcement what they need to crack down, take control, and stop this poison from claiming more lives.' Miller-Meeks also reintroduced a bipartisan bill Thursday requiring social media companies and other communication service providers to alert law enforcement officials when illegal drug distributions occur on their platforms. All of Iowa's delegates voted in favor of Trump's rescission bill to axe $9 billion in previously approved funding for programs including the U.S. Agency for International Aid, The Corporation for Public Broadcasting and National Public Radio. The rescission bill passed both chambers of Congress Friday with a vote of 51-48 in the Senate and 216-213 in the House. This marks the second time in over three decades Congress has approved a presidential rescission request. Ernst praised the cuts to USAID, citing 'abuses' such as an alleged $148,000 sent to a pickle-maker in Ukraine through USAID and $20 million spent on Sesame Street programming in Iraq. 'If we are ever going to get serious about our debt crisis, Congress needs to pass a rescissions bill like this every single week,' she stated in a press release. Hinson responded to the bill with a statement on X: 'President Trump is the first president to actually deliver on real savings for the American people and end the culture of wasteful spending in Washington.' Grassley took to X as well to state 'Fed govt is $36 TRILLION in debt Last night Sen Republicans voted to roll back DC's out of control spending.' He added that Republicans plan to build on the provisions in the 'big, beautiful bill' going forward. Miller-Meeks called the rescission cuts a one of two 'big wins for the American people' in an X post. She also cheered the passing of a defense appropriations bill increasing military spending. Democrats in both the House and Senate voted against passing the rescission bill. Several Democratic legislators criticized the rescission bill for cutting funding from public broadcasting that will impact rural news sources and withdrawing U.S. support from countries in need. Ernst led an amendment to the defense appropriations bill to require all defense spending be posted on the public website This amendment will directly target 'Other Transaction Agreements' which are flexible spending agreements not subject to standard acquisition laws and requirements. 'I am ending Pentagon bureaucrats' game of hide and seek with your tax dollars,' Ernst stated in a press release. 'Americans have a right to know where their hard-earned dollars are going. I've long been working to make the Pentagon more transparent and accountable and will continue to work to review the hidden receipts.' The expansive defense bill passed through the House with a split vote of 221-209 on Friday. It allocates nearly $832 billion for provisions such as: Basic pay increase for all military members by 3.8% starting 2026 Codifies Trump's executive order to end military diversity, equity and inclusion programs $13 billion for missile defense and space programs $7 billion for 'classified space superiority programs.' $2.6 billion for hypersonic missiles. $1.15 billion for counterdrug programs $500 million for Israeli Missile Defense $500 million for Taiwan Security Operative Miller-Meeks responded to the provisions in a press release stating: 'This bill gives our troops the pay raise they deserve and the resources they need to defend this country.' The bill moves to the Senate for reconciliation. Cedar Rapids is set to receive $25 million in federal funding through the Grassley-backed Infrastructure and Jobs Act of 2021. The funding is allocated for a 'flood resiliency project' and road improvements on highway I-380. 'I'm happy to announce that the City of Cedar Rapids is receiving a $25 million award to improve its flood resilience and infrastructure,' Grassley said in a press release. 'You can imagine how important this funding is for Cedar Rapids, after the city has been hit by devastating floods. These federal dollars will be put to good use to strengthen the Cedar Rapids community.' SUPPORT: YOU MAKE OUR WORK POSSIBLE